Resources Contact Us Home
Purine derivatives as A3 and A1 adenosine receptor agonists

Image Number 5 for United States Patent #7825126.

Disclosed are (N)-methanocarba adenine nucleosides of the formula: ##STR00001## as highly potent A.sub.3 adenosine receptor agonists, pharmaceutical compositions comprising such nucleosides, and a method of use of these nucleosides, wherein R.sub.1-R.sub.6 are as defined in the specification. These nucleosides are contemplated for use in the treatment a number of diseases, for example, inflammation, cardiac ischemia, stroke, asthma, diabetes, and cardiac arrhythmias. The invention also provides compounds that are agonists of both A.sub.1 and A.sub.3 adenosine receptors for use in cardioprotection.

  Recently Added Patents
Reverse mapping method and apparatus for form filling
Systems and methods to provide report part via a web service
Digital broadcasting transmission and reception system, and a signal processing method using turbo processing and turbo decoding
Surfcraft fin
Change management automation tool
Mobile camera localization using depth maps
Architecture, system and method for testing resistive type memory
  Randomly Featured Patents
Direct detection of RNA mediated by reverse transcriptase lacking RNAse H function
Method for repairing fiberglass boat hulls
Apparatus and method for replacing a battery pack in a battery powered vehicle
Configurable power tank
Functional nucleic acid probes and uses thereof
Process for preparing phenylalkanoic acids
Magnetostrictive stress sensor
Method and apparatus for detecting a sinusoidal signal using a counter and queue
Fixing mechanism for use in image forming apparatus
Wavelet-based artificial neural net combustion sensing